Tamoxifen and breast cancer prevention: are we aware of the risks?
Mandeville
R
R
Immunology Research Centre, Institut Armand-Frappier, Université du Québec, Laval.
Houde
M
M
D001943:Breast Neoplasms / Q000517:prevention & control*; D019008:Drug Resistance, Neoplasm; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000139:chemically induced
D004965:Estrogen Antagonists; D013629:Tamoxifen